Dual Programmed Cell Death Pathways Induced by p53 Transactivation Overcome Resistance to Oncolytic Adenovirus in Human Osteosarcoma CellsJoe Hasei, Toshiyoshi Fujiwara, Toshifumi Ozaki et al.|Molecular Cancer Therapeutics|2013Cited by 62
Preclinical Evaluation of Telomerase-Specific Oncolytic Virotherapy for Human Bone and Soft Tissue SarcomasTsuyoshi Sasaki, Toshiyoshi Fujiwara, Toshiyuki Kunisada et al.|Clinical Cancer Research|2011Cited by 52